CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B903. A total of 2 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 26 | -25.7% | 0.00% | – |
| Q3 2018 | $1,000 | -80.0% | 35 | -66.0% | 0.00% | – |
| Q2 2018 | $5,000 | +66.7% | 103 | -55.4% | 0.00% | – |
| Q1 2018 | $3,000 | -40.0% | 231 | -60.5% | 0.00% | – |
| Q4 2017 | $5,000 | -54.5% | 585 | -18.5% | 0.00% | – |
| Q3 2017 | $11,000 | +1000.0% | 718 | +165.9% | 0.00% | – |
| Q2 2017 | $1,000 | -92.9% | 270 | -56.0% | 0.00% | -100.0% |
| Q1 2017 | $14,000 | +1300.0% | 614 | +219.8% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 192 | +58.7% | 0.00% | – |
| Q3 2016 | $1,000 | -93.8% | 121 | -70.8% | 0.00% | -100.0% |
| Q2 2016 | $16,000 | 0.0% | 414 | -5.9% | 0.00% | 0.0% |
| Q1 2016 | $16,000 | -71.4% | 440 | +26.4% | 0.00% | -75.0% |
| Q4 2015 | $56,000 | +522.2% | 348 | +49.4% | 0.00% | +300.0% |
| Q3 2015 | $9,000 | -80.0% | 233 | +30.2% | 0.00% | -75.0% |
| Q2 2015 | $45,000 | -48.9% | 179 | +55.7% | 0.00% | -60.0% |
| Q1 2015 | $88,000 | -5.4% | 115 | -65.5% | 0.01% | -9.1% |
| Q4 2014 | $93,000 | – | 333 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $972,000 | 0.52% |
| GROUP ONE TRADING, L.P. | 239,700 | $3,107,000 | 0.05% |
| Citadel Advisors | 104,500 | $1,354,000 | 0.00% |